ADENOCARCINOMA OF LUNG, RESPONSE TO TYROS
|
ADENOCARCINOMA OF LUNG, SOMATIC
|
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2
|
AMYOTROPHIC LATERAL SCLEROSIS 19
|
AORTIC ANEURYSM, FAMILIAL THORACIC 7
|
BLADDER CANCER, SOMATIC, INCLUDED
|
BREAST CANCER, SUSCEPTIBILITY TO
|
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME
|
CARDIOFACIOCUTANEOUS SYNDROME 1
|
CARDIOFACIOCUTANEOUS SYNDROME 3
|
CARDIOFACIOCUTANEOUS SYNDROME 4
|
CATARACT 6, AGE-RELATED CORTICAL
|
CEREBRAL INFARCTION, SUSCEPTIBILITY TO
|
CHRONIC MYELOID LEUKEMIA, RESISTANT TO IMATINIB
|
COFFIN-LOWRY SYNDROME
|
COFFIN-LOWRY SYNDROME, MILD
|
COLON CANCER, HEREDITARY NONPOLYPOSIS, TYPE 6, SOMATIC, INCLUDED
|
COLON CANCER, SOMATIC
|
COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 6
|
COLORECTAL CANCER, SOMATIC
|
COLORECTAL CANCER, SOMATIC, INCLUDED;;
|
CROUZON SYNDROME
|
DEFICIENCY
|
DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS
|
DIABETES MELLITUS, NONINSULIN-DEPENDENT
|
DIABETES MELLITUS, TYPE II
|
ENDOCRINE-CEREBROOSTEODYSPLASIA
|
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2
|
ESOPHAGEAL CANCER, SOMATIC
|
FG SYNDROME 4
|
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA
|
GASTRIC CANCER, SOMATIC
|
GLIOBLASTOMA, SOMATIC
|
GLYCOGEN STORAGE DISEASE IXC
|
HARTSFIELD SYNDROME
|
HEMANGIOMA, CAPILLARY INFANTILE, SOMATIC
|
HEPATOCELLULAR CARCINOMA, CHILDHOOD TYPE, SOMATIC
|
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1
|
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5
|
HYPOCHONDROPLASIA
|
HYPOGONADOTROPIC HYPOGONADISM 2 WITH ANOSMIA
|
HYPOGONADOTROPIC HYPOGONADISM 2 WITH ANOSMIA, SUSCEPTIBILITY TO
|
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA, SUSCEPTIBILITY
|
HYPOGONADOTROPIC HYPOGONADISM 2 WITHOUT ANOSMIA
|
HYPOGONADOTROPIC HYPOGONADISM 2 WITHOUT ANOSMIA, SUSCEPTIBILITY TO
|
IN
|
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS
|
INSULIN RESISTANCE
|
INSULIN RESISTANCE, INCLUDED
|
IRAK4 DEFICIENCY
|
JUVENILE POLYPOSIS SYNDROME
|
LADD SYNDROME
|
LEUKEMIA, PHILADELPHIA CHROMOSOME-POSITIVE, RESISTANT TO IMATINIB
|
LOEYS-DIETZ SYNDROME, TYPE 1A
|
LOEYS-DIETZ SYNDROME, TYPE 1B
|
LOEYS-DIETZ SYNDROME, TYPE 1B, INCLUDED
|
LOEYS-DIETZ SYNDROME, TYPE 2B
|
LYMPHEDEMA, HEREDITARY, I
|
LYMPHEDEMA, HEREDITARY, IA
|
LYMPHOMA, NON-HODGKIN, SOMATIC
|
LYMPHOPROLIFERATIVE SYNDROME 1
|
MALFORMATIONS
|
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME
|
MELANOMA, MALIGNANT, SOMATIC
|
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA
|
MENTAL RETARDATION, X-LINKED 19
|
MENTAL RETARDATION, X-LINKED 30
|
MENTAL RETARDATION, X-LINKED, WITH NYSTAGMUS
|
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA
|
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB
|
MULTIPLE MYELOMA, SOMATIC, INCLUDED;;
|
MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA, SUSCEPTIBILITY TO
|
MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR
|
NEPHRONOPHTHISIS 9 (NPHP9)
|
NEUROBLASTOMA, SUSCEPTIBILITY TO, 3
|
NEUROPATHY, HEREDITARY SENSORY, TYPE II
|
NONSMALL CELL LUNG CANCER, RESISTANCE TO TYROSINE KINASE INHIBITOR
|
NONSMALL CELL LUNG CANCER, RESPONSE TO TYROSINE KINASE INHIBITOR IN,
|
NOONAN SYNDROME 7
|
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY
|
OGUCHI DISEASE 2
|
OVARIAN CANCER, SOMATIC
|
PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET
|
PARKINSON DISEASE 6, EARLY-ONSET
|
PARKINSON DISEASE 6, LATE-ONSET, SUSCEPTIBILITY TO
|
PARKINSON DISEASE 8, AUTOSOMAL DOMINANT
|
PARKINSON DISEASE, AUTOSOMAL RECESSIVE EARLY-ONSET, DIGENIC, PINK1/DJ1
|
PERSISTENT MULLERIAN DUCT SYNDROME, TYPE II
|
PEUTZ-JEGHERS SYNDROME
|
PFEIFFER SYNDROME
|
PHEOCHROMOCYTOMA, INCLUDED
|
PHEOCHROMOCYTOMA, SOMATIC, IN
|
PROSTATE CANCER, PROGRESSION AND METASTASIS OF
|
PULMONARY HYPERTENSION, PRIMARY, 1
|
PULMONARY HYPERTENSION, PRIMARY, 1, WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA
|
PULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED, INCLUDED
|
RENAL AGENESIS
|
RENAL CELL CARCINOMA, PAPILLARY, 1
|
RENAL CELL CARCINOMA, PAPILLARY, 1, SOMATIC
|
RETINITIS PIGMENTOSA 38
|
RETINITIS PIGMENTOSA 62
|
RETINITIS PIGMENTOSA 62 (RP62)
|
SADDAN DYSPLASIA
|
SCAPHOCEPHALY, MAXILLARY RETRUSION, AND MENTAL RETARDATION, INCLUDED
|
SELECTIVE T-CELL DEFECT
|
SHORT RIB-POLYDACTYLY SYNDROME 2A (SRPS2A)
|
SHORT RIB-POLYDACTYLY SYNDROME, TYPE IIA
|
SOMATIC
|
SPERMATOCYTIC SEMINOMA, SOMATIC, INCLUDED
|
SPERMATOGENIC FAILURE 5
|
SPINOCEREBELLAR ATAXIA 14
|
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE
|
T-CELL IMMUNODEFICIENCY, RECURRENT INFECTIONS, AUTOIMMUNITY, AND CARDIAC
|
TESTICULAR TUMOR, SOMATIC
|
THANATOPHORIC DYSPLASIA, TYPE I
|
THANATOPHORIC DYSPLASIA, TYPE I, INCLUDED
|
THANATOPHORIC DYSPLASIA, TYPE II
|
THROMBOCYTOPENIA 2
|
THYROID CARCINOMA, FAMILIAL MEDULLARY
|
THYROID CARCINOMA, FAMILIAL MEDULLARY, INCLUDED
|
THYROID CARCINOMA, FOLLICULAR, SOMATIC, INCLUDED
|
THYROID CARCINOMA, PAPILLARY, SOMATIC, INCLUDED;;|
|
THYROID CARCINOMA, SPORADIC MEDULLARY, INCLUDED;;
|
TO
|
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL
|